Northeast Financial Consultants Inc Cognition Therapeutics Inc Transaction History
Northeast Financial Consultants Inc
- $2.22 Billion
- Q1 2025
A detailed history of Northeast Financial Consultants Inc transactions in Cognition Therapeutics Inc stock. As of the latest transaction made, Northeast Financial Consultants Inc holds 63,351 shares of CGTX stock, worth $20,905. This represents 0.0% of its overall portfolio holdings.
Number of Shares
63,351
Previous 24,500
158.58%
Holding current value
$20,905
Previous $18,000
44.44%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CGTX
# of Institutions
58Shares Held
13.1MCall Options Held
0Put Options Held
0-
Bios Capital Management, LP Fort Worth, TX6MShares$1.98 Million3.19% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ2.21MShares$727,7740.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.24MShares$408,9250.0% of portfolio
-
Sigma Planning Corp Ann Arbor, MI608KShares$200,7680.01% of portfolio
-
Voss Capital, LLC Houston, TX450KShares$148,5000.02% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $7.49M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...